التداخل بين كاربامازيبين وسيكلوفوسفاميد

The rate of metabolism and the leukopenic activity of cyclophosphamide are reportedly increased by chronic co-administration of CYP3A4 inducers.

There is a potential for increased cyclophosphamide toxicity when coadministered with carbamazepine.

Cyclophosphamide Cyclophosphamide is an inactive prodrug and is converted to its active metabolite in part by CYP3A.